196 related articles for article (PubMed ID: 11972979)
1. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
Guptan RC; Thakur V; Safary A; Sarin SK
Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
Burgess MA; Rodger AJ; Waite SA; Collard F
Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects.
Prado V; Riedemann S; Ibarra H; Potin M
Int J Infect Dis; 2002 Jun; 6(2):129-33. PubMed ID: 12121601
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix.
Greub G; Genton B; Safary A; Thoelen S; Frei PC
Vaccine; 2000 Dec; 19(9-10):1113-7. PubMed ID: 11137246
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
8. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
10. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
11. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
13. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
Levie K; Beran J; Collard F; Nguyen C
Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
[TBL] [Abstract][Full Text] [Related]
16. A new accelerated vaccination schedule for rapid protection against hepatitis A and B.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Vollmar J; Sänger R
Vaccine; 2002 Jan; 20(7-8):1157-62. PubMed ID: 11803077
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
De Schryver A; Verstrepen K; Vandersmissen L; Vandermeeren N; Vernaillen I; Vranckx R; Van Damme P; van Sprundel M
J Viral Hepat; 2011 Apr; 18(4):e5-10. PubMed ID: 20735800
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
20. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
